| John P Fezza, MD | |
|
1370 E Venice Ave Ste 205, Venice, FL 34285-9084 | |
| (941) 488-2020 | |
| Not Available |
| Full Name | John P Fezza |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 32 Years |
| Location | 1370 E Venice Ave Ste 205, Venice, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184715187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME76288 (Florida) | Secondary |
| 207WX0200X | Ophthalmology - Ophthalmic Plastic And Reconstructive Surgery | ME76288 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Sight Pl | 1658340294 | 51 |
News Archive
Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease.
A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.
Congenital heart valve defects appear in 2 percent of all live births, making them the most common type of birth defect. While some of these defects have been linked to specific genetic mutations, the majority have no clearly definable genetic cause, suggesting that epigenetic factors - changes in gene expression versus an alteration in the genetic code - play an important role.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
› Verified 2 days ago
| Entity Name | Center For Sight Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386718468 PECOS PAC ID: 1658340294 Enrollment ID: O20040929001217 |
News Archive
Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease.
A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.
Congenital heart valve defects appear in 2 percent of all live births, making them the most common type of birth defect. While some of these defects have been linked to specific genetic mutations, the majority have no clearly definable genetic cause, suggesting that epigenetic factors - changes in gene expression versus an alteration in the genetic code - play an important role.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John P Fezza, MD 1360 E Venice Ave, Venice, FL 34285-9066 Ph: (941) 488-2020 | John P Fezza, MD 1370 E Venice Ave Ste 205, Venice, FL 34285-9084 Ph: (941) 488-2020 |
News Archive
Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease.
A new £2.7 million international training network project, led by a team at Lancaster University, will develop a generation of medical statisticians dedicated to achieving early stage drug development success.
Congenital heart valve defects appear in 2 percent of all live births, making them the most common type of birth defect. While some of these defects have been linked to specific genetic mutations, the majority have no clearly definable genetic cause, suggesting that epigenetic factors - changes in gene expression versus an alteration in the genetic code - play an important role.
A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
› Verified 2 days ago
P Dee G Stephenson, M.D., P.A. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Palermo Pl, Venice, FL 34285 Phone: 941-485-1121 Fax: 941-486-0571 | |
Dr. Jesse Thomas Mccann, MD PHD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 Fax: 941-484-2200 | |
Dr. Priya Mary Mathews, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 | |
Donald Alvin Mceachern, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1511 Tamiami Trl S, Suite 201, Venice, FL 34285 Phone: 941-497-2138 Fax: 941-493-2598 | |
Dr. Mark Anthony Johnson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 811 Ridgewood Avenue, Venice, FL 34285 Phone: 941-480-0600 Fax: 941-485-8090 | |
Dr. William John Mestrezat, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1360 E Venice Ave, Venice, FL 34285 Phone: 941-488-2020 Fax: 941-484-2200 |